Literature DB >> 33504636

Presence of SARS-CoV-2 Transcripts in the Choroid Plexus of MS and Non-MS Patients With COVID-19.

Vidmante Fuchs1, Michael Kutza1, Sven Wischnewski1, Nikolaus Deigendesch1, Luc Lutz1, Laila Kulsvehagen1, Gerda Ricken1, Ludwig Kappos1, Alexandar Tzankov1, Simon Hametner1, Stephan Frank1, Lucas Schirmer1, Anne-Katrin Pröbstel2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33504636     DOI: 10.1212/NXI.0000000000000957

Source DB:  PubMed          Journal:  Neurol Neuroimmunol Neuroinflamm        ISSN: 2332-7812


× No keyword cloud information.
  8 in total

1.  Mechanisms of Entry Into the Central Nervous System by Neuroinvasive Pathogens.

Authors:  Navid Valizadeh; Emily A Rudmann; Isaac H Solomon; Shibani S Mukerji
Journal:  J Neuroophthalmol       Date:  2022-02-15       Impact factor: 4.415

2.  Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint.

Authors:  Marika Alborghetti; Gianmarco Bellucci; Antonietta Gentile; Chiara Calderoni; Ferdinando Nicoletti; Ruggero Capra; Marco Salvetti; Diego Centonze
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

3.  Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.

Authors:  Martin Stangel; Klemens Ruprecht; Brigitte Wildemann; Sven Jarius; Florence Pache; Peter Körtvelyessy; Ilijas Jelčić; Mark Stettner; Diego Franciotta; Emanuela Keller; Bernhard Neumann; Marius Ringelstein; Makbule Senel; Axel Regeniter; Rea Kalantzis; Jan F Willms; Achim Berthele; Markus Busch; Marco Capobianco; Amanda Eisele; Ina Reichen; Rick Dersch; Sebastian Rauer; Katharina Sandner; Ilya Ayzenberg; Catharina C Gross; Harald Hegen; Michael Khalil; Ingo Kleiter; Thorsten Lenhard; Jürgen Haas; Orhan Aktas; Klemens Angstwurm; Christoph Kleinschnitz; Jan Lewerenz; Hayrettin Tumani; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2022-01-20       Impact factor: 8.322

Review 4.  Neurological Complications of COVID-19: Underlying Mechanisms and Management.

Authors:  Ghaydaa A Shehata; Kevin C Lord; Michaela C Grudzinski; Mohamed Elsayed; Ramy Abdelnaby; Hatem A Elshabrawy
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

Review 5.  Multiple sclerosis and COVID-19: The Swedish experience.

Authors:  Anne-Marie Landtblom; Shala G Berntsson; Inger Boström; Ellen Iacobaeus
Journal:  Acta Neurol Scand       Date:  2021-05-24       Impact factor: 3.915

6.  Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2.

Authors:  Molly Brady; Conor McQuaid; Alexander Solorzano; Angelique Johnson; Abigail Combs; Chethana Venkatraman; Akib Rahman; Hannah Leyva; Wing-Chi Edmund Kwok; Ronald W Wood; Rashid Deane
Journal:  Commun Biol       Date:  2021-11-22

Review 7.  COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences.

Authors:  Berenice Martínez-Salazar; Melle Holwerda; Chiara Stüdle; Indre Piragyte; Nadia Mercader; Britta Engelhardt; Robert Rieben; Yvonne Döring
Journal:  Front Cell Dev Biol       Date:  2022-02-15

Review 8.  The choroid plexus and its role in the pathogenesis of neurological infections.

Authors:  Derick Thompson; Catherine A Brissette; John A Watt
Journal:  Fluids Barriers CNS       Date:  2022-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.